Search results for "compounds"

showing 10 items of 3372 documents

When Does Gold Behave as a Halogen? Predicted Uranium Tetraauride and Other MAu4 Tetrahedral Species, (M = Ti, Zr, Hf, Th)

2003

Quantum chemical calculations suggest that a series of molecules with the general formula MAu4 are stable, where M = U, Th, and a group-4 atom. They correspond to Au in the formal valence state -1 and indicate that gold can act as a ligand similar to the halogen series. Of the MAu4 species studied, UAu4, the first predicted mixed gold uranium compound, has a short M-Au bond distance, 2.71 A, which would locate Au between Br and I from the bond length point of view in the U-tetrahalide series. Energetically, the U-Au bond is weaker than the corresponding U-Br and U-I bonds.

Valence (chemistry)LigandStereochemistrychemistry.chemical_elementGeneral MedicineGeneral ChemistryElectronic structureUraniumBiochemistryCatalysisBond lengthCrystallographyColloid and Surface ChemistrychemistryGold CompoundsMolecular vibrationAtomHalogenddc:540TetrahedronMolecule
researchProduct

Theoretical characterization of the lowest-energy absorption band of pyrrole

2002

The lowest-energy band of the electronic spectrum of pyrrole has been studied with vibrational resolution by using multiconfigurational second-order perturbation theory (CASPT2) and its multistate extension (MS–CASPT2) in conjunction with large atomic natural orbital-type basis sets including Rydberg functions. The obtained results provide a consistent picture of the recorded spectrum in the energy region 5.5–6.5 eV and confirm that the bulk of the intensity of the band arises from a ππ∗ intravalence transition, in contradiction to recent theoretical claims. Computed band origins for the 3s,3p Rydberg electronic transitions are in agreement with the available experimental data, although new…

Valence (chemistry)Organic compounds ; Vibrational states ; Perturbation theory ; Rydberg states ; Orbital calculationsAb initioGeneral Physics and AstronomyPerturbation theoryRydberg statesUNESCO::FÍSICA::Química físicaOrbital calculationschemistry.chemical_compoundsymbols.namesakechemistryEnergy absorptionAtomic electron transitionExcited stateOrganic compoundsRydberg formulasymbolsTheoretical chemistryVibrational statesPhysical and Theoretical ChemistryAtomic physics:FÍSICA::Química física [UNESCO]Pyrrole
researchProduct

Salikteņi rakstos par tirgvedību

2018

Rakstība angļu valodā vienmēr ir bijusi diezgan sarežģīta. Salikteņi ir vārdi, kam nav noteiktas rakstības sistēmas, tādēļ cilvēki tos raksta dažādi. Tādējādi šī darba mērķis ir analizēt salikteņus rakstos par tirgvedību. Kvalitatīvā un kvantitatīvā analīze tika izmantota kā pētniecības metode, un analīze tika veikta par salikteņiem, kas atrodami rakstos par tirgvedību vienā britu un vienā amerikāņu tirgvedības žurnālā. Šis pētījums ir parādījis, ka pārstāvētākais salikteņu veids ir īstie salikteņi (proper compounds) un izplatītākā salikteņu rakstība ir tos rakstīt kā vienu vārdu jeb “koprakstījumā” (solid compounds). Pētījuma rezultāti apstiprina, ka rakstos par tirgvedību izmantoto salikt…

ValodniecībaCompoundsCompound typesArticles on marketingQualitative and quantitative analysisSpelling of compounds
researchProduct

Synthesis, structural studies and reactivity of vanadium complexes with tridentate (OSO) ligand

2007

The direct reaction between [VCl(3)(thf)3] or [VO(OEt)3] and 2,2'-thiobis{4-(1,1,3,3-tetramethyl-butyl)phenol (tbopH(2)) leads to the formation of [V(2)(micro-tbop-kappa(3)O,S,O)2Cl(2)(CH(3)CN)(2)] (1).4CH(3)CN or [V(2)(micro-OEt)2(O)2(tbop-kappa(3)O,S,O)2] (2), respectively, in high yield. Compounds 1 and 2 were characterized by chemical and physical techniques including X-ray crystallography and variable temperature magnetic susceptibility studies (J = -29.1 cm(-1)) for 1. Complexes 1 and 2 were supported on MgCl2 and when activated with aluminium alkyls, were found to effectively polymerize ethene to produce polyethylene with a narrow molecular weight distribution M(w)/M(n) approximately…

Vanadium CompoundsLigandStereochemistrySpectrum AnalysisMagnesium ChlorideTemperatureVanadiumchemistry.chemical_elementCrystallography X-RayLigandsMedicinal chemistryMagnetic susceptibilityCatalysisCatalysisMolecular WeightInorganic ChemistrychemistryPolymerizationPolyethyleneYield (chemistry)NitrogenaseAluminum OxideOrganometallic CompoundsMolar mass distributionReactivity (chemistry)Dalton Trans.
researchProduct

Low-temperature molecular layer deposition using monifunctional aromatic precursors and ozone-based ring-opening reactions

2017

Molecular layer deposition (MLD) is an increasingly used deposition technique for producing thin coatings consisting of purely organic or hybrid inorganic-organic materials. When organic materials are prepared, low deposition temperatures are often required to avoid decomposition, thus causing problems with low vapor pressure precursors. Monofunctional compounds have higher vapor pressures than traditional bi- or trifunctional MLD precursors, but do not offer the required functional groups for continuing the MLD growth in subsequent deposition cycles. In this study, we have used high vapor pressure monofunctional aromatic precursors in combination with ozone-triggered ring-opening reactions…

Vapor pressureHydrostatic pressure02 engineering and technologyphenols01 natural sciencesdepositionchemistry.chemical_compoundhybrid materialsElectrochemistryGeneral Materials Sciencecharacterizationinfrared spectroscopyta116Spectroscopyring opening reactionTrifluoromethylvapor pressurehybrid organic-inorganiclow-temperatureSurfaces and Interfacesself assembly021001 nanoscience & nanotechnologyCondensed Matter Physicsdecay (organic)hydrostatic pressure0210 nano-technologyHybrid materialLayer (electronics)Inorganic chemistryta221mechanismnegative ions010402 general chemistrycomplex mixturesinorganic coatingsBenzaldehydeAtomic layer depositionPhenolta216ta115ta114aromatic compoundsmonofunctional aromaticstemperature0104 chemical sciencesozonechemistryALDatomic layer depositionMLDLangmuir
researchProduct

Synthesis of honokiol analogues and evaluation of their modulating action on VEGF protein secretion and telomerase-related gene expressions

2017

A group of 36 biphenyl derivatives structurally related to honokiol were synthesized by means of Suzuki coupling reactions. Their cytotoxicities were evaluated and compared to that of honokiol. Some of the compounds were then evaluated for their ability to downregulate the secretion of the VEGF protein and the expression of the VEGF, hTERT, and c-Myc genes; the two latter involved in the activation of telomerase in tumoral cells. Some of the synthetized derivatives showed promising pharmacological features as they exhibited IC50 values in low micromolar range, good therapeutic margins, and a multiple mode of action on tumor cells based on the inhibition of VEGF and, at the same time, of the…

Vascular Endothelial Growth Factor A0301 basic medicineHonokiolTelomeraseAngiogenesishonokiol analoguesGene ExpressionEnzyme-Linked Immunosorbent AssayBiologytelomeraseBiochemistryLignans03 medical and health scienceschemistry.chemical_compoundangiogenesisDownregulation and upregulationDrug DiscoveryHumansSecretionTelomerase reverse transcriptaseTelomerasePharmacologyRegulation of gene expressionBiphenyl CompoundsOrganic ChemistryVEGFHEK293 Cells030104 developmental biologySecretory proteinc-MycchemistryMCF-7 CellsCancer researchMolecular Medicinegene regulationhTERTHT29 Cells
researchProduct

Dexamethasone Inhibits the Pro-Angiogenic Potential of Primary Human Myoblasts

2021

Tissue regeneration depends on the complex processes of angiogenesis, inflammation and wound healing. Regarding muscle tissue, glucocorticoids (GCs) inhibit pro-inflammatory signalling and angiogenesis and lead to muscle atrophy. Our hypothesis is that the synthetic GC dexamethasone (dex) impairs angiogenesis leading to muscle atrophy or inhibited muscle regeneration. Therefore, this study aims to elucidate the effect of dexamethasone on HUVECs under different conditions in mono- and co-culture with myoblasts to evaluate growth behavior and dex impact with regard to muscle atrophy and muscle regeneration. Viability assays, qPCR, immunofluorescence as well as ELISAs were performed on HUVECs,…

Vascular Endothelial Growth Factor A0301 basic medicineMuscle tissueCD31endocrine systemQH301-705.5AngiogenesisMyoblasts SkeletalNeovascularization PhysiologicInflammationdexamethasonehuman primary myoblastsArticleCatalysisInorganic Chemistry03 medical and health sciences0302 clinical medicineHuman Umbilical Vein Endothelial Cellsmedicinepolycyclic compoundsHumansMyocyteBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologySpectroscopyHUVECsTube formationChemistryOrganic ChemistryGeneral Medicineco-cultureVEGFCoculture TechniquesMuscle atrophyComputer Science ApplicationsCell biologyChemistry030104 developmental biologymedicine.anatomical_structureGene Expression RegulationCD31medicine.symptomWound healing030217 neurology & neurosurgeryhormones hormone substitutes and hormone antagonistsInternational Journal of Molecular Sciences
researchProduct

An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorecta…

2014

Abstract Author Summary Background. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR-2) are believed to mediate angiogenesis in colorectal cancer (CRC). Ramucirumab (RAM; IMC-1121B) is a human IgG1 monoclonal antibody that inhibits VEGF ligand binding to VEGFR-2, inhibiting VEGFR-2 activation and signaling. Methods. Patients with metastatic CRC, Eastern Cooperative Oncology Group performance status 0–1, and adequate organ function who had not received chemotherapy for metastatic disease received RAM and the modified FOLFOX-6 regimen every 2 weeks. Endpoints included progression-free survival (PFS), objective response rate, overall survival, and safety. The sample size wa…

Vascular Endothelial Growth Factor ACancer ResearchPathologymedicine.medical_specialtyOrganoplatinum CompoundsAngiogenesisColorectal cancerLeucovorinAntibodies Monoclonal HumanizedDisease-Free SurvivalDrug Administration ScheduleRamucirumabchemistry.chemical_compoundAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansNeoplasm Metastasisbusiness.industryClinical Trial ResultsAntibodies MonoclonalKinase insert domain receptormedicine.diseaseVascular Endothelial Growth Factor Receptor-2Vascular endothelial growth factorVascular endothelial growth factor ATreatment OutcomeOncologychemistryFluorouracilMonoclonalCancer researchFluorouracilbusinessColorectal Neoplasmsmedicine.drugProtein Binding
researchProduct

Characterization of Membrane-Bound Cyclic Nucleotide Phosphodiesterases from Bovine Aortic Smooth Muscle

1992

This study reports the isolation and characterization of cyclic nucleotide phosphodiesterases (PDEs) associated with membrane fraction in comparison to cytosolic forms from bovine aorta. DEAE-Sephacel chromatography of a solubilized membrane fraction from a homogenate, prepared under isotonic conditions in the presence of protease inhibitors, yielded one major peak of PDE activity that specifically hydrolyzed cAMP and was not stimulated by calmodulin: It appeared to contain two subtypes of PDE. The first subtype belonged to the cyclic GMP (cGMP)-inhibited PDE family, (PDE III): It had an apparent Km value of 0.4 microM and was potently inhibited by cGMP, LY186126, and cilostamide. The secon…

Vascular smooth muscleCalmodulinPhosphodiesterase InhibitorsMuscle Smooth Vascularchemistry.chemical_compoundCytosolCalmodulinCyclic AMPmedicineAnimalsheterocyclic compoundsCyclic GMPRolipramPharmacologyCilostamidebiologyCyclic nucleotide phosphodiesterasePhosphoric Diester HydrolasesHydrolysisCell MembraneBiological membranemusculoskeletal systemenzymes and coenzymes (carbohydrates)Mechanism of actionBiochemistrychemistryEnzyme inhibitorbiology.proteinCattleChromatography Thin Layersense organsmedicine.symptomCardiology and Cardiovascular Medicinecirculatory and respiratory physiologymedicine.drugJournal of Cardiovascular Pharmacology
researchProduct

Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1).

2012

Identification, synthesis and structure-activity relationship of small-molecule VIPR1 antagonists encompassing two chemical series are described.

Vasoactive intestinal peptide (VIP)Settore MED/09 - Medicina InternaReceptors Vasoactive Intestinal Polypeptide Type IClinical BiochemistryVasoactive intestinal peptidePharmaceutical ScienceAntineoplastic AgentsThiophenesBiochemistrySmall Molecule LibrariesStructure-Activity RelationshipCell Line TumorDrug DiscoveryStructure–activity relationshipHumansReceptorMolecular BiologyChemistryVasoactive intestinal peptide receptorOrganic ChemistryBiphenyl CompoundsSmall Molecule LibrariesSmall moleculeHigh-Throughput Screening AssaysBiochemistryCell cultureVasoactive intestinal peptide receptor (VIPR)Molecular MedicineDrug Screening Assays AntitumorVIPR1Bioorganicmedicinal chemistry letters
researchProduct